期刊文献+

抗Cyclin D1胞内抗体AD5N对宫颈癌HeLa细胞的影响

Effects of Anti-cyclin D1 Intrabody AD5N on HeLa Cervical Cancer Cells
下载PDF
导出
摘要 目的:抗Cyclin D1胞内抗体AD5N对宫颈癌细胞增殖的抑制效应分析。方法:将携带抗Cyclin D1胞内抗体AD5N的真核表达载体pcDNA3.1-AD5N,利用脂质体介导法稳定转染宫颈癌HeLa细胞,G418筛选阳性细胞株,进一步通过Westernblot、MTT法及流式细胞术分析该胞内抗体的细胞内表达和抗肿瘤效应。结果:AD5N在稳定筛选的细胞株中有效表达,与空细胞和空质粒转染的细胞株相比,明显抑制HeLa细胞增殖,并诱导细胞凋亡(P<0.01),细胞周期G0-G1期指数增高10.35%,S期指数下降15.77%,凋亡细胞指数上升6.38%。结论:抗Cyclin D1胞内抗体AD5N基因的表达,抑制宫颈癌细胞的增殖,阻滞细胞周期进展,并诱导细胞凋亡。 Objective: To evaluate the effects of anti-cyclin D1 intrabody AD5N on the proliferation of HeLa cervical cancer cells. Methods: The control plasmids (pcDNA3.1) and recombinant plasmids with intrabody (pcD- NA3.1-AD5N) were stably transfected into HeLa cells using lipofectamine 2000. G418 selection was performed to obtain the positive cell clones that were named HeLa/pcDNA3.1 or Hela/pcDNA3.1-AD5N. Western blot, MTT assay and fluorescence-activated cell sorting were conducted to investigate the expression of intrabody in HeLa cells and its anti-tumor effects. Results: AD5N was expressed efficiently in HeLa/pcD- NA3.1-AD5N cells. Compared with the control, the expression of AD5N in HeLa/pcDNA3.1-AD5N cells significantly inhibited proliferation, markedly arrested the cell cycle, and induced apoptosis of HeLa cells (P〈0.01). The ratio of cells in G0-G1 phase was increased by 10.35%, and the percentage of cells in S phase was decreased by 15.77%. The apoptosis index was increased by 6.38%. Conclusion: The expression of anti-cyclinD1 intrabody AD5N inhibits cell proliferation, arrests the cell cycle, and induces apoptosis of HeLa cervical cancer cells in vitro.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2008年第16期942-944,948,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学青年科学基金项目(编号:30200256) 吉林省科技发展计划项目资助(编号:20050410-3)~~
关键词 CYCLIND1 胞内抗体 增殖 宫颈癌 CyclinD1 Intrabody Proliferation Uterine cervical cancer
  • 相关文献

参考文献13

  • 1Cao T, Heng BC. Intracellular andbodies(intrabodies) versus RNA interference for therapeutic applications[J]. Ann Clin Lab Sci, 2005, 35(3): 227-229.
  • 2Lo AS, Zhu Q, Marasco WA. IntraceUular antibodies (intrabodies) and their therapeutic potential[J]. Handb Exp Pharmacol, 2008, (181): 343-373.
  • 3Alvarez RD, Barnes MN, Gomez-NavarroJ, et al. A cancer gene therapy approach utilizing an anti---erbB--2 single-chain anti- body---encoding adenovirus (AD21): a phase Ⅰ trial[J]. Clin Cancer Res, 2000, 6(8): 3081-3087.
  • 4Li L, Gondi CS, Dinh DH, et al.Transfection with anti-p65 intrabody suppresses invasion and angiogenesis in glioma cells by blocking nuclear factor-kappaB transcriptional activity[J].Glin Cancer Res, 2007, 13(7) :2178--2190.
  • 5郭科军,葛莉莉,薛晖.年轻妇女宫颈癌的发病趋势及临床病理特点[J].中国肿瘤临床,2007,34(5):269-270. 被引量:13
  • 6孙津明,费新雄,孙明霞,李育刚.检测宫颈癌中肿瘤细胞增殖相关因子的表达[J].中国肿瘤临床,2008,35(7):387-390. 被引量:4
  • 7Deshpande A, Sicinski P, Hinds PW. Cyclins and cdks in development and cancer: a perspective[J]. Oncogene, 2005, 24(17): 2909-2915.
  • 8Malumbres M, Barbadd M. Is Cyclin D1---CDK4 kinase a bona fide cancer target[J]? Cancer Cell, 2006, 9(1): 2-4.
  • 9Kozar K, Ciemerych MA, Rebel VI, et al. Mouse development and cell proliferation in the absence of D-cyclins[J]. Cell, 2004, 118(4): 477--491.
  • 10Arber N, Doki Y, Han EK, et al. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells [J]. Cancer Res, 1997, 57(8): 1569-1574.

二级参考文献13

  • 1郑向奎,李春仲,段文都,王香琢,王毅,郭剑,刘会燕,李杰.Rb、p16、CyclinD1基因蛋白在大肠癌中的表达及临床意义[J].中国肿瘤临床,2005,32(21):1235-1238. 被引量:4
  • 2王秋旭,王大力,孙长伏,王天祥.PTEN蛋白在舌鳞癌中的表达及意义[J].上海口腔医学,2006,15(2):133-135. 被引量:2
  • 3Sherris J, Herdman C, Elias C. Cervical cancer in the developing world[J]. West J Med ,2001, 175(4): 231-233.
  • 4Macgregor JE, Teper S.Mortafity from carcinoma of cervix uteri in Britain[j]. Lancet, 1978, 2(8093): 774-776.
  • 5EUiott PM, TattersaU MH, Goppleson M, et al. Changing character of cervical cancer in young women [j]. BMJ, 1989, 298(6669): 288-290.
  • 6Stockton D, Cooper P, Lonsdale RN. Changing incidence of invasive adefiocarcinoma of the uterine cervix in East Anglia [j]. J Med Screen, 1997, 4(1): 40-43.
  • 7Vizcalno AP, Moreno V, Bosch FX, et al. Internadonal trends in the incidence of cervical cancer: Ⅰ. Adenocarcinoma and adenosquamous cell carcinomas[j]. IntJ Cancer, 1998, 75(4): 536-545.
  • 8连利娟,主编.林巧稚妇科肿瘤学[M].第3版.北京:人民卫生出版社.1999.209-222.
  • 9Kaufman RH, Adam E, Vonka V. Human papillomavirus infection and cervical carcinoma [J]. Clin Obste Gynecol, 2000, 43(2): 363 -380.
  • 10Zondervan KT, Carpenter LM, Painter R, et al. Oral contracepfives and cervical cancer-further findings from the Oxford Family Planning Association contraceptive study[J]. BrJ Cancer, 1996, 73 (10): 1291-1297.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部